Inactief instrument

Andere talen UMN Pharma Inc.

Aandelen

4585

JP3944320005

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

AIM ImmunoTech Inc. Enters into Mutual Confidentiality Agreement with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd	27-04-20
Shionogi & Co., Ltd. completed the acquisition of 52.74% stake in UMN Pharma Inc. for ¥5 billion.	12-12-19
Shionogi & Co., Ltd. made a tender offer to acquire 69.6% stake in UMN Pharma Inc for approximately ¥6.7 billion.	30-10-19
UMN Pharma Inc. Reports Non-Consolidated Earnings Results for the Six Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2019	31-07-19
UMN Pharma Inc. Reports Non-Consolidated Earnings Results for the Quarter Ended March 31, 2018; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2018	27-04-18
UMN Pharma Inc. Announces Non Consolidated Earnings Results for the Year Ended December 31, 2017; Provides Earnings Guidance for the Full Year of 2018	14-02-18
UMN Pharma Inc. announced that it has received ¥1.639 billion in funding from Shionogi & Co., Ltd.	16-11-17
UMN Pharma Inc. announced that it expects to receive ¥1.64 billion in funding from Shionogi & Co., Ltd.	31-10-17
Umn Pharma Inc. Announces Non-Consolidated Earnings Results for the Nine Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending December. 31, 2017	31-10-17
UMN Pharma Inc.(TSE:4585) dropped from S&P Global BMI Index	18-09-17
UMN Pharma Inc. Announces Nonconsolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Nonconsolidated Earnings Guidance for the Year Ending December 31, 2017	31-07-17
Umn Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2017; Provide Earnings Guidance for the Year 2017	28-04-17
UMN Pharma Inc. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2016; Provides Earnings Guidance for the Year Ending December 31, 2017	14-02-17
API Co., Ltd. acquired 50% stake in Unigen KK from UMN Pharma Inc..	31-01-17
Umn Pharma Inc. Announces Consolidated Earnings Results for the First Nine Months Ended September 30, 2016; Provides Earnings Guidance for the Year Ending March 31, 2016	31-10-16
UMN Pharma Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2016; Provides Earnings Guidance for the Year Ending December 31, 2016	29-07-16
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2016	28-04-16
UMN Pharma Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2015	12-02-16
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Nine Month Ended September 30, 2015; Updates Consolidated Earnings Guidance for the Year Ending March 31, 2016	30-10-15
UMN Pharma Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2015; Revises Earnings Guidance for the Year Ending December 31, 2015	31-07-15

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen UMN Pharma Inc.

Aandelen

4585

JP3944320005

Andere talen

Filters